Walleye Capital’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-20,687
Closed -$241K – 5984
2026
Q2
$241K Buy
+20,687
New +$295K ﹤0.01% 3355
2024
Q4
– Sell
-10,993
Closed -$204K – 4922
2024
Q3
$204K Buy
+10,993
New +$221K ﹤0.01% 3994

Other funds holding CLB

Walleye Capital's CLB Position: Q3 2026 in Review

Walleye Capital sold out of Core Laboratories (CLB) in Q3 2026, closing a stake of 20,687 shares — an estimated $241K sold.

Walleye Capital first reported a position in CLB in Q3 2024 and held it in 2 quarters. The position peaked at $241K in Q2 2026. 179 funds tracked by Wall St. Rank hold CLB as of Q3 2026.

  • Walleye Capital reported no remaining Core Laboratories position as of Q3 2026 after selling out during the quarter.
  • Walleye Capital sold 20,687 Core Laboratories shares in Q3 2026, an estimated $241K.
  • Walleye Capital first reported a position in Core Laboratories in Q3 2024 and held it in 2 quarters.
  • Walleye Capital's Core Laboratories position peaked at $241K in Q2 2026.
  • 179 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.